활동성 인공판막 심내막염: 임상 양상, 검사 소견 및 중기 수술 성적 = Active Prosthetic Valve Endocarditis: The Clinical Profile, Laboratory Findings and Mid-term Surgical Results

국문 초록 (Abstract)

배경: 인공판막 심내막염은 자연판막 심내막염보다 초기 임상양상이 불량하고, 심내막의 감염 뿐 아니라 주변 조직으로 염증 파급이 용이하다. 특히, 합병증을 동반하여 악화된 임상양상으로 술 전 충분한 항생제 치료를 기대할 수 없는 상태(활동성 심내막염)에서 판막 재치환술을 시행하는 경우는 만족스럽지 못한 술 후 예후를 가진다. 본 연구는 활동성 인공판막 심내막염의 임상 양상, 검사 소견 및 중기 수술 성적 알아보기 위해 수행되었다. 대상 및 방법: 1998년 1월부터 2008년 7월까지 감염성 심내막염으로 진단 및 수술이 이루어진 276명의 환자 중 인공판막 심내막염으로 수술이 이루어진 경우는 31명이었다. 이 중 24명의 활동성 인공판막 심내막염 환자를 연구 대상으로 하였다. 결과: 열감이 가장 흔한 임상증상이었으나, 전신성 색전증을 동반한 경우도 8예(33.3%)였으며, 이 중 5예(20.8%)는 중추신경계가 이환되었다. 경식도 초음파 검사상 우종(vegetation)이 가장 많이 관찰된 소견이며, 포도상 구균(Staphylococcus species)이 배양된 주된 원인 균주였다. 42.1±36.9달의 평균 추적 관찰 기간 동안 조기사망 4예, 만기사망 4예 있었으며, 누적 생존율은 1년 후에는 79%, 3년 후에는 73%, 5년 후에는 66%, 7년 후에는 49.5%였다. 결론: 악화된 임상양상 등의 이유로 술 전 충분한 항생제 치료를 기대할 수 없는 활동성 인공판막 심내막염은 술 후 불량한 예후를 가진다. 그럼에도 불구하고, 조기 수술은 물론, 정상 조직이 노출이 될 때까지 광범위한 염증 조직 제거하는 것이 환자의 생존율을 높일 수 있는 방법이라 생각된다.

다국어 초록 (Multilingual Abstract)

Background: Prosthetic valve endocarditis usually presents with clinical symptoms that are more severe than native valve endocarditis, and prosthetic valve endocarditis shows the spread of infection into the surrounding tissue as well as into the superficial endocardial layers. The postoperative prognosis is especially poor for valve re-replacement for the cases of active endocarditis that are unable to receive a full-course of pre-antibiotic therapy due to complications and the ensuing clinical aggravation. The aim of this study was to evaluate the clinical profiles, laboratory findings and mid-term surgical results of active prosthetic valve endocarditis. Material and Method: Among the 276 surgically treated infective endocarditis patients who were treated during the period from January 1998 to July 2008, 31 patients were treated for prosthetic valve endocarditis. Among these patients, 24 received surgical treatment for an 'active' state, and they were selected for evaluation. Result: The most frequently encountered symptom was a febrile sensation. Eight cases (33.3%) were accompanied by systemic thromboembolism, among which 5 cases (20.8%) had an affected central nervous system. 'Vegetations' were most commonly found on transesophageal echocardiography, and the 'Staphylococcus species' were the most frequent pathogens. There were 4 deaths in the immediate postoperative period, and an additional 4 patients died during the follow-up period (Mean± SD, 42.1±36.9 months). The cumulative survival rate was 79% at 1 year, 73% at 3 years, 66% at 5 year, and 49.5% at 7 years. Conclusion: The cases of active prosthetic valve endocarditis that were unable to receive a full course of preoperative antibiotics therapy generally have a poor prognosis. Nevertheless, early surgery and extensive resection of all the infected tissue is pivotal in improving the survival rate of patients with surgically treated active prosthetic valve endocarditis.

참고문헌 (Reference)

1 Gillinov AM, "Valve replacement in patients with endocarditis and neurologic defici" 61 : 1125-1130, 1996

2 Moon MR, "Treatment of endocarditis with valve replacement: the question of tissue versus mechanical prosthesis" 71 : 1164-1171, 2001

3 Eishi K, "Surgical management of infective endocarditis associated with cerebral complications. Multi-center retrospective study in Japan" 110 : 1745-1755, 1995

4 Piper C, "Stroke is not a contraindication for urgent valve replacement in acute infective endocarditis" 10 : 703-711, 2001

5 Hyde JA, "Strategies for prophylaxis against prosthetic valve endocarditis: a review article" 7 : 316-326, 1998

6 Vlessis AA, "Starr A. Risk, diagnosis and management of prosthetic valve endocarditis: a review" 6 : 443-465, 1997

7 Vilacosta I, "Risk of embolization after institution of antibiotic therapy for infective endocarditis" 39 : 1489-1495, 2002

8 Calderwood SB, "Risk factors for the development of prosthetic valve endocarditis" 72 : 31-37, 1985

9 Calderwood SB, "Prosthetic valve endocarditis; analysis of factors affecting outcome of therapy" 92 : 776-783, 1986

10 Douglas JL, "Prosthetic valve endocarditis, in Infective endocarditis. 2nd ed" Raven Press 375-396, 1992

11 Fang G, "Prosthetic valve endocarditis resulting from nosocomial bacteremia. A prospective multicenter study" 119 : 560-567, 1993

12 Davenport J, "Prosthetic valve endocarditis 1976- 1987: antibiotics, anticoagulation, and stroke" 21 : 993-999, 1990

13 Piper C, "Prosthetic valve endocarditis" 85 : 590-593, 2001

14 Ivert TS, "Prosthetic valve endocarditis" 69 : 223-232, 1984

15 Wilson WR, "Prosthetic valve endocarditis" 57 : 155-161, 1982

16 Vongpatanasin W, "Prosthetic heart valve" 335 : 407-416, 1996

17 Ruttmann E, "Neurological outcome of septic cardioembolic stroke after infective endocarditis" 37 : 2094-2099, 2006

18 Salgado AV, "Neurologic complications of endocarditis: a 12-year experience" 39 : 173-178, 1989

19 Romano G, "Native versus primary prosthetic valve endocarditis; comparison of clinical features and long-term outcome in 353 patients" 13 : 200-208, 2004

20 Horstkotte D, "Late prosthetic valve endocarditis" 16 (16): 39-47, 1995

21 Lopez J, "Definition, clinical profile, microbiological spectrum, and prognostic factors of early-onset prosthetic valve endocarditis" 28 : 760-765, 2007

22 Aranki SF, "Aortic valve endocarditis. Determenants of early survival and late morbidity" 90 : 175-182, 1994

23 Wilson WR, "Anticoagulation therapy and central nervous system complications in patients with prosthetic valve endocarditis" 57 : 1004-1007, 1978

24 Carpenter JL, "Anticoagulation in prosthetic valve endocarditis" 76 : 1372-1375, 1983